Department of Anesthesiology, Tri-Service General Hospital and National Defense Medical Center, Taipei, Taiwan, Republic of China.
School of Public Health, National Defense Medical Center, Taipei, Taiwan, Republic of China.
PLoS One. 2020 Mar 17;15(3):e0230290. doi: 10.1371/journal.pone.0230290. eCollection 2020.
Previous researches have shown that anesthetic techniques may influence the patients' outcomes after cancer surgery. Here, we studied the relationship between the type of anesthetic techniques and patients' outcomes following elective robot-assisted radical prostatectomy.
This was a retrospective cohort study of patients who received elective, robot-assisted radical prostatectomy between January 2008 and December 2018. Patients were grouped according to the anesthesia they received, namely desflurane or propofol. A Kaplan-Meier analysis was conducted, and survival curves were presented from the date of surgery to death. Univariable and multivariable Cox regression models were used to compare hazard ratios for death after propensity matching. Subgroup analyses were performed for tumor-node-metastasis stage and disease progression. The primary outcome was overall survival, and the secondary outcome was postoperative biochemical recurrence.
A total of 365 patients (24 deaths, 7.0%) under desflurane anesthesia, and 266 patients (2 deaths, 1.0%) under propofol anesthesia were included. The all-cause mortality rate was significantly lower in the propofol anesthesia than in the desflurane anesthesia during follow-up (P = 0.001). Two hundred sixty-four patients remained in each group after propensity matching. The propofol anesthesia was associated with improved overall survival (hazard ratio, 0.11; 95% confidence interval, 0.03-0.48; P = 0.003) in the matched analysis. Subgroup analyses showed that patients under propofol anesthesia had less postoperative biochemical recurrence than those under desflurane (hazard ratio, 0.20; 95% confidence interval, 0.05-0.91; P = 0.038) in the matched analysis.
Propofol anesthesia was associated with improved overall survival in robot-assisted radical prostatectomy compared with desflurane anesthesia. In addition, patients under propofol anesthesia had less postoperative biochemical recurrence.
先前的研究表明,麻醉技术可能会影响癌症手术后患者的预后。在这里,我们研究了麻醉技术类型与择期机器人辅助根治性前列腺切除术患者预后之间的关系。
这是一项回顾性队列研究,纳入了 2008 年 1 月至 2018 年 12 月期间接受择期机器人辅助根治性前列腺切除术的患者。根据所接受的麻醉方式将患者分为七氟醚或丙泊酚组。采用 Kaplan-Meier 分析,从手术日期到死亡日期绘制生存曲线。采用单变量和多变量 Cox 回归模型比较倾向匹配后死亡的风险比。进行了肿瘤-淋巴结-转移分期和疾病进展的亚组分析。主要结局为总生存,次要结局为术后生化复发。
共有 365 例患者(七氟醚麻醉组 24 例死亡,7.0%;丙泊酚麻醉组 2 例死亡,1.0%)纳入研究。在随访期间,丙泊酚麻醉组的全因死亡率明显低于七氟醚麻醉组(P=0.001)。倾向匹配后,每组各有 264 例患者。匹配分析显示,丙泊酚麻醉与改善的总生存相关(风险比,0.11;95%置信区间,0.03-0.48;P=0.003)。亚组分析显示,匹配分析中,丙泊酚麻醉组患者术后生化复发率低于七氟醚麻醉组(风险比,0.20;95%置信区间,0.05-0.91;P=0.038)。
与七氟醚麻醉相比,丙泊酚麻醉与机器人辅助根治性前列腺切除术患者的总生存改善相关。此外,丙泊酚麻醉患者术后生化复发率较低。